MENU

VTGN VistaGen Therapeutics Forecast, Technical & Fundamental Analysis

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VTGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VTGN is expected to report earnings to fall 94.68% to -5 cents per share on June 27

VistaGen Therapeutics VTGN Stock Earnings Reports
Q1'23
Est.
$-0.05
Q2'23
Beat
by $1.31
Q4'22
Beat
by $0.02
Q3'22
Missed
by $0.01
Q2'22
Missed
by $0.02
The last earnings report on August 10 showed earnings per share of -93 cents, beating the estimate of -225 cents. With 26.18K shares outstanding, the current market capitalization sits at 97.94M.
A.I. Advisor
published General Information

General Information

a developer of embryonic stem cells for drug discovery and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
343 Allerton Avenue
Phone
+1 650 577-3600
Employees
33
Web
https://www.vistagen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SICP0.530.01
+2.50%
Silvergate Capital Corporation
PWCDF28.750.50
+1.76%
Power Corp. of Canada
ZLNDY12.770.19
+1.47%
ZALANDO SE
GENGF0.520.01
+1.21%
Gear Energy Ltd
DASTY36.48-0.13
-0.36%
Dassault Systemes SA

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NKTR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NKTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-1.63%
NKTR - VTGN
60%
Loosely correlated
-2.84%
CLRB - VTGN
33%
Poorly correlated
+1.28%
NRIX - VTGN
33%
Poorly correlated
-0.38%
BEAM - VTGN
31%
Poorly correlated
+7.82%
PLX - VTGN
31%
Poorly correlated
-0.86%
More